The Oasis Health Journal · Submitted July 7, 2026 · 5:17 PM ET
Ginkgo biloba comes from a tree so old it watched the dinosaurs show up, get comfortable, and leave. Somehow it survived all of that and ended up in your grandmother's pill organizer, sold as the memory supplement, the one you take so you can remember where you left the other supplements. Here is the odd part. Whether ginkgo works seems to depend less on the capsule and more on who is swallowing it.
The raw leaf is not really the point. The trials that matter use a standardized extract called EGb 761, boiled down to 24 percent flavonoid glycosides and 6 percent terpene lactones, a group that includes the ginkgolides and bilobalide (which sound less like plant chemistry and more like minor characters in a space opera). Those compounds widen blood vessels in the brain, block a clotting signal called platelet-activating factor, and mop up free radicals. The theory is tidy: better plumbing upstairs, better thinking. Theory is where a lot of supplements go to nap, so researchers ran the actual trials.
Here is what the marketing tends to skip. As a dementia preventer, ginkgo is a flop. The Ginkgo Evaluation of Memory study, published in JAMA in 2008, put 3,069 adults aged 75 and older on 240 mg of EGb 761 a day, or a placebo, and followed them for about six years. New dementia in the ginkgo group versus placebo came out to roughly a tie. A few years later the French GuidAge trial tried the same idea on about 2,850 older adults who had complained to their doctors about their memory, this time for five years. Ginkgo did not slow the slide toward Alzheimer's there either. If your memory is fine and you want to keep it that way, ginkgo is not the bodyguard you were promised.
Now turn the question around. A recent meta-analysis in the World Journal of Biological Psychiatry pooled four randomized trials, 782 people who already had mild dementia, and asked something narrower: does the extract help the folks who are already struggling? This time the answer was yes. At 240 mg a day, EGb 761 beat placebo on thinking, on everyday tasks like getting dressed and managing money, and on quality of life, with effect sizes the authors called medium to large. The World Federation of Societies of Biological Psychiatry now files the extract alongside the prescription drugs doctors reach for in early dementia. Same molecule, opposite verdict. The only thing that changed was the person holding the bottle.
That is the entire ginkgo story in one line: it is a treatment hunting for the right patient, not a vitamin for the worried well. Handing it to a sharp 70-year-old to prevent trouble is like hiring a plumber for a house with no leaks. Handing it to someone whose thinking has already started to wobble is a different job, and that is the job the evidence actually backs. Our standardized ginkgo biloba is built for that second situation, not as a preventive charm.
One detail worth pinning down. The trials that showed anything used a standardized 240 mg extract, not whatever tired capsule was cheapest by the register. Ginkgo held to that 24 percent flavonoid, 6 percent terpene ratio is the version that got tested. A bottle that just says 'ginkgo' with no standardization is a bit of a mystery box, and mystery boxes rarely reproduce clinical results. If you want the thing the studies studied, buy the thing the studies studied.
Safety, quickly. On its own, standardized ginkgo has a fairly clean record. A 2011 systematic review and meta-analysis did not find that it raised bleeding risk compared with placebo. The asterisk shows up when you mix it with blood thinners. A 2025 analysis reported that pairing ginkgo with warfarin nudged bleeding events upward (hazard ratio 1.38), though the absolute increase was small. So if you take warfarin, aspirin, or other antiplatelet drugs, or you have surgery on the calendar, ginkgo is a conversation to have with your doctor, not a solo decision at the supplement shelf.
Ginkgo is also not the only tool in the drawer. Some people set it next to phosphatidylserine, one of the few brain nutrients with a qualified FDA claim on its record, or citicoline, which helps rebuild the membranes your neurons are built from. And the least glamorous option, plain omega-3 fish oil, keeps quietly turning up in cognitive-aging research. None of them are magic. All of them work better inside a life that already has sleep, movement, and people worth talking to.
A word on how we handle it. Professional-grade plant extracts fade as they sit, because the whole value is the concentration of active molecules. So we source fresh per order instead of letting inventory age in a warehouse. Your order ships a little slower and lands a little stronger. For a compound whose entire job is potency, that trade is worth the wait.
This article is for education only and is not medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk with a qualified healthcare professional before starting ginkgo, especially if you take blood thinners or have a procedure scheduled.
Sources
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia: a meta-analysis of patient subgroups in randomised controlled trials (World Journal of Biological Psychiatry, 2024)
- The Ginkgo Evaluation of Memory (GEM) Study (NCCIH)
- Ginkgo biloba for Prevention of Dementia: A Randomized Controlled Trial, GEM (JAMA, 2008)
- Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease, GuidAge (The Lancet Neurology, 2012)
- Neuroprotective effects of Ginkgo biloba extract (Cellular and Molecular Life Sciences)
- Is There a Risk of Bleeding Associated with Standardized Ginkgo biloba Extract Therapy? A Systematic Review and Meta-analysis (2011)
- Impact of Ginkgo biloba drug interactions on bleeding risk and coagulation profiles (PLOS One, 2025)

Leave a comment